Page 22 - CSTE_Annual-Report_2017-18

Position Statements • 18-ID-06: Revisions to the Surveillance Case Definition, Case

Classification, Public Health Reporting, and National Notification
for Listeriosis
In May 2018, the CSTE Executive Board released the new CSTE Policy and • 18-ID-07: Public Health Reporting and National Notification for
Position Statement Process, the result of a nine month effort to review Hepatitis A
and overhaul the previous process. There are now three mechanisms
• 18-ID-08: Public Health Reporting and National Notification
through which the CSTE membership can provide a voice on matters
for Salmonella enterica serotype Typhi (S. Typhi) and Salmonella
relating to public health epidemiology practice and policy: CSTE
enterica serotypes Paratyphi A, B (tartrate negative), and C (S.
Position Statements, and new CSTE Briefs and CSTE Letters. For detailed
Paratyphi) Infections
information on the new CSTE Policy and Position Statement Process, visit
www.cste.org/page/PPSP.

Each spring, position statements are submitted to be discussed and CSTE’s Position Statement
voted on by the membership at the Annual Conference in June.
Below is the list of vetted 2018 Position Statements approved by CSTE archive dates back to
membership.
1986
2018 Position Statements

• 18-EH-01: Standardized Surveillance for Carbon Monoxide
Poisoning

• 18-ID-01: Standardized Case Definition for Surveillance of RSV-
Associated Mortality
There have been
• 18-ID-02: Case Definition for Non-pestis Yersiniosis
677
• 18-ID-03: Revision to the Case Definition for National Diphtheria
Surveillance
• 18-ID-04: Update to Yellow Fever Case Definition
total Position Statements
• 18-ID-05: Standardized Case Definition for Candida auris clinical
and colonization/screening cases and National Notification of since then
C. auris case, clinical

Annual C onf erence 22